Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-12

FDA Approved: NOREPINEPHRINE BITARTRATE — Supplemental Application (Civica, Inc.)

View source ↗

Summary

FDA approved Civica, Inc.'s supplemental application for norepinephrine bitartrate (ANDA 211359).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Norepinephrine bitartrate (Norepinephrine bitartrate)

Snippet

SUPPL AP for NOREPINEPHRINE BITARTRATE (NOREPINEPHRINE BITARTRATE)